FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

First Quarterly Performance Report Released for the 2017-2018 Fiscal Year
April 15, 2018

The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading


House Bill 323 – Meningococcal and Shingles Vaccines
March 30, 2018

Click here for more information on authorization for pharmacists to administer meningococcal and shingles vaccines under certain circumstances. Continue reading